As stated in our extensive report; the Global Advanced Wound Care Market accounted forUSD 9.1 Billionin 2021.
Due to the access and affordability of surgical care, there is an increase in the number of surgical procedures performed, which is the critical driver of the Advanced Wound Care Market. Moreover, surgical procedures are generally accompanied by wound infections, excessive bleeding, tissue damage, etc. Therefore, the Advanced Wound Care products like honey wound dressing come with antimicrobial agents that have become a workable option to reduce the infection and wound bacterial colonization for recovering the curing procedure. Also, the high prevalence of chronic injuries such as diabetic foot ulcers, venous leg ulcers, and acute injuries is one of the major factors resulting in the increasing demand for Advanced Wound Care products.
Furthermore, the increasing elderly population base worldwide, along with the growing cases of diabetes patients, is accountable for the occurrence of acute and chronic wounds in the last decades. In addition, the increasing investment in research & devolvement and technological advancements will positively impact the market. Also, the support from the government to produce high-quality products in emergent nations is expected to drive market sales in the coming years.
North Americaholds a significant share in theAdvanced Wound Care Market and will probably continue this trend in the estimated period. This surge is due to the increasing surgical procedure cases and the region's well-developed healthcare infrastructure. In addition, the growth in the accident cases like road accidents, burns, and trauma events, along with the penetration of Advanced Wound Care products, will support the regional market growth in the future. Besides, the presence of several key participants and the rise in many acquisitions across emerging regions will propel the Advanced Wound Care Market growth during the forecast period.
Notable and prominent players in the Global Advanced Wound Care Market include- 3M Company (US), Smith & Nephew PLC (UK), ConvaTec Group PLC (UK), Coloplast A/S (Denmark), Molnlycke Health Care AB (Sweden), Integra LifeSciences Holdings Corporation (US), PAUL Hartmann AG (Germany), B. Braun Melsungen AG (Germany), Cardinal Health Inc. (US), Organogenesis Holdings Inc. (US), Misonix, Inc. (US), MiMedx Group Inc. (US), Zimmer Biomet Holdings Inc. (US), Lohmann & Rauscher GmbH & Co. KG (Germany), DeRoyal Industries Inc. (US), Medline Industries Inc. (US), DermaRite Industries LLC (US), Kerecis (Iceland), Advancis Medical (UK), Winner Medical Co. Ltd. (China), Hollister Incorporated (US), Mil Laboratories Pvt. Ltd. (India), Shield Line (US), ZENI Medical (US), Carilex Medical (Germany), Pensar Medical LLC (US), Wuhan VSD Medical Science & Technology Co. Ltd. (China), Haromed B.V. (Belgium) and others.